Basal pulmonary vascular resistance and nitric oxide responsiveness late after fontan-type operation

Circulation

Volumn 107, Issue 25, 2003, Pages 3204-3208

  Khambadkone, Sachin ^a   Li, J ^b   De Leval, M R ^b   Cullen, S ^a   Deanfield, J E ^b   Redington, A N ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b Great Ormond Street Hospital ^*

Author keywords

Endothelial dysfunction; Fontan procedure; Pulmonary vascular resistance

Indexed keywords

NITRIC OXIDE; OXYGEN;

ADOLESCENT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; ENDOTHELIUM; FEMALE; FONTAN PROCEDURE; HUMAN; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; MALE; MASS SPECTROMETRY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SCHOOL CHILD;

ADMINISTRATION, INHALATION; ADOLESCENT; AGE FACTORS; ANGIOGRAPHY; BLOOD FLOW VELOCITY; CHILD; ENDOTHELIUM, VASCULAR; FEMALE; FONTAN PROCEDURE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEMODYNAMIC PROCESSES; HUMANS; MALE; NITRIC OXIDE; OXYGEN CONSUMPTION; PULMONARY CIRCULATION; PULSATILE FLOW; TIME; VASCULAR RESISTANCE;

EID: 0038078913     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000074210.49434.40     Document Type: Article

References (26)

1. Gentles TL, Mayer JE Jr, Gauvreau K, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg. 1997;114:376-391.
2. Knott-Craig CJ, Danielson GK, Schaff HV, et al. The modified Fontan operation: an analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution. J Thorac Cardiovasc Surg. 1995;109:1237-1243.
3. Hakim TS. Flow-induced release of EDRF in the pulmonary vasculature: site of release and action. Am J Physiol. 1994;267(1 pt 2):H363-H369.
4. Goldman AP, Delius RE, Deanfield JE, et al. Pharmacological control of pulmonary blood flow with inhaled nitric oxide after the fenestrated Fontan operation. Circulation. 1996;94(9 suppl):II44-II48.
5. Ishizaka T, Kumon K, Yahagi N, et al. Inhaled nitric oxide after Fontan type operation [in Japanese]. Rinsho Kyobu Geka. 1994;14:323-326.
6. Yahagi N, Kumon K, Tanigami H, et al. Inhaled nitric oxide for the postoperative management of Fontan-type operations. Ann Thorac Surg. 1994;57:1371-1373.
7. Gamillscheg A, Zobel G, Urlesberger B, et al. Inhaled nitric oxide in patients with critical pulmonary perfusion after Fontan-type procedures and bidirectional Glenn anastomosis. J Thorac Cardiovasc Surg. 1997; 113:435-442.
8. Vargo TA. Cardiac catheterisation measurements. In: Garson A, Bricker TJ, Fisher DJ, et al, eds. The Science and Practice of Pediatric Cardiology. 2nd ed. Baltimore: Williams & Wilkins; 1998:981-1024.
9. Mair DD, Puga FJ, Danielson GK. The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 patients. J Am Coll Cardiol. 2001;37:933-939.
10. Cohen AJ, Cleveland DC, Dyck J, et al. Results of the Fontan procedure for patients with univentricular heart. Ann Thorac Surg. 1991;52:1266-1270.
11. Fontan F, Kirklin JW, Fernandez G, et al. Outcome after a "perfect" Fontan operation. Circulation. 1990;81:1520-1536.
12. Kaulitz R, Ziemer G, Luhmer I, et al. Modified Fontan operation in functionally univentricular hearts: preoperative risk factors and intermediate results. J Thorac Cardiovasc Surg. 1996;112:658-664.
13. Goldman AP, Delius RE, Deanfield JE, et al. Pharmacological control of pulmonary blood flow with inhaled nitric oxide after the fenestrated Fontan operation. Circulation. 1996;94(9 suppl):II44-II48.
14. Kiely DG, Lee AF, Struthers AD, et al. Nitric oxide: an important role in the maintenance of systemic and pulmonary vascular tone in man. Br J Clin Pharmacol. 1998;46:263-266.
15. Chen YF, Oparil S. Endothelial dysfunction in the pulmonary vascular bed. Am J Med Sci. 2000;320:223-232.
16. Rossi GP, Seccia TM, Nussdorfer GG. Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. Int Rev Cytol. 2001;209:241-272.
17. Brett SJ, Chambers J, Bush A, et al. Pulmonary response of normal human subjects to inhaled vasodilator substances. Clin Sci (Lond). 1998; 95:621-627.
18. Celermajer DS, Dollery C, Burch M, et al. Role of endothelium in the maintenance of low pulmonary vascular tone in normal children. Circulation. 1994;89:2041-2044.
19. Kiely DG, Lee AF, Struthers AD, et al. Nitric oxide: an important role in the maintenance of systemic and pulmonary vascular tone in man. Br J Clin Pharmacol. 1998;46:263-266.
20. Van Camp JR, Yian C, Lupinetti FM. Regulation of pulmonary vascular resistance by endogenous and exogenous nitric oxide. Ann Thorac Surg. 1994;58:1025-1029.
21. Penny DJ, Redington AN. Doppler echocardiographic evaluation of pulmonary blood flow after the Fontan operation: the role of the lungs. Br Heart J. 1991;66:372-374.
22. Raj JU, Kaapa P, Anderson J. Effect of pulsatile flow on microvascular resistance in adult rabbit lungs. J Appl Physiol. 1992;72:73-81.
23. Busse R, Fleming I. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium-derived relaxing factors. J Vasc Res. 1998;35:73-84.
24. Morgan VL, Graham TP Jr, Roselli RJ, et al. Alterations in pulmonary artery flow patterns and shear stress determined with three-dimensional phase-contrast magnetic resonance imaging in Fontan patients. J Thorac Cardiovasc Surg. 1998;116:294-304.
25. Hsia TY, Khambadkone S, Redington AN, et al. Effects of respiration and gravity on infradiaphragmatic venous flow in normal and Fontan patients. Circulation. 2000;19(suppl 3):III148-III153.
26. Kouatli AA, Garcia JA, Zellers TM, et al. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation. 1997; 96:1507-1512.